PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in PAVmed Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +2 vs. Q1 2024
- Shares held
- 1.10M
- +142.8K (+15.0%) vs. Q1 2024
- Total value
- $931.9K
- −$1.10M (−54.1%) vs. Q1 2024
- New holders
- 6
- 5 more added
- Sold out
- 4
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PAVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $5.56M |
| Q1 2026 | 21 | $5.26M |
| Q4 2025 | 32 | $468.8K |
| Q3 2025 | 36 | $677.4K |
| Q2 2025 | 32 | $755.8K |
| Q1 2025 | 31 | $873.5K |
| Q4 2024 | 26 | $653.8K |
| Q3 2024 | 22 | $1.38M |
| Q2 2024 | 26 | $931.9K |
| Q1 2024 | 24 | $2.03M |
| Q4 2023 | 26 | $3.10M |
| Q3 2023 | 65 | $3.67M |
| Q2 2023 | 58 | $3.78M |
| Q1 2023 | 61 | $3.76M |
| Q4 2022 | 64 | $4.62M |
| Q3 2022 | 73 | $10.9M |
| Q2 2022 | 76 | $11.5M |
| Q1 2022 | 96 | $27.0M |
| Q4 2021 | 108 | $65.5M |
| Q3 2021 | 109 | $198.9M |
| Q2 2021 | 101 | $134.7M |
| Q1 2021 | 92 | $80.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding PAVmed Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Manhattan Co | 500,000 | $407.5K | 0.00% | +75,000+17.6% | Added |
| Vanguard Group Inc | 295,390 | $240.7K | 0.00% | −5,151−1.7% | Reduced |
| Axiom Advisory, LLC | 38,955 | $70.7K | 0.00% | +38,955 | New |
| BlackRock Inc. | 74,912 | $61.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 73,634 | $60.0K | 0.00% | +10,274+16.2% | Added |
| Two Sigma Securities, LLC | 25,225 | $20.6K | 0.00% | +25,225 | New |
| State Street Corp | 20,854 | $17.0K | 0.00% | −127−0.6% | Reduced |
| Virtu Financial LLC | 15,099 | $12.0K | 0.00% | +15,099 | New |
| Northern Trust Corp | 11,706 | $9.54K | 0.00% | −46−0.4% | Reduced |
| XML Financial, LLC | 10,067 | $8.21K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,704 | $7.91K | 0.00% | +7,247+295.0% | Added |
| Morgan Stanley | 5,068 | $4.13K | 0.00% | −61−1.2% | Reduced |
| CWM, LLC | 4,672 | $4.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,795 | $3.91K | 0.00% | +4,795 | New |
| Wells Fargo & Company | 3,902 | $3.18K | 0.00% | −3,242−45.4% | Reduced |
| CIBC Private Wealth Group, LLC | 836 | $664 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 420 | $425 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 116 | $94 | 0.00% | −12−9.4% | Reduced |
| Bank of America Corp | 79 | $65 | 0.00% | +72+1,028.6% | Added |
| Parallel Advisors, LLC | 78 | $64 | 0.00% | +78 | New |
| M&R Capital Management Inc | 67 | $55 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 37 | $30 | 0.00% | +1+2.8% | Added |
| GWM Advisors LLC | 7 | $6 | 0.00% | +7 | New |
| Thompson Investment Management, Inc. | 4 | $3 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 11 | $0 | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −21,129−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −3,612−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −134−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |